Back to top
more

Amgen (AMGN)

(Delayed Data from NSDQ)

$319.66 USD

319.66
1,467,828

+2.18 (0.69%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $319.25 -0.41 (-0.13%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (83 out of 252)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Zacks News

Amgen (AMGN) Dips More Than Broader Markets: What You Should Know

Amgen (AMGN) closed the most recent trading day at $270.12, moving -1.85% from the previous trading session.

Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again

Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know

Amgen (AMGN) closed at $264.39 in the latest trading session, marking a +1.05% move from the prior day.

Sweta Killa headshot

Dow Jones Beats S&P 500 in 2022: 5 Hot Stocks

The Dow Jones fared as the best of the indexes and five stocks -- Chevron (CVX), Merck (MRK), Travelers (TRV), Amgen (AMGN), and Caterpillar (CAT) -- gained in double-digits in 2022.

Amgen (AMGN) Gains But Lags Market: What You Should Know

Amgen (AMGN) closed at $263.16 in the latest trading session, marking a +0.67% move from the prior day.

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks Investment Ideas feature highlights: Caterpillar, Chevron and Amgen

Caterpillar, Chevron and Amgen have been highlighted in this Investment Ideas article.

Derek Lewis headshot

3 Top Performing Blue-Chips of 2022

Many investors have flocked to blue-chip stocks in 2022 to shield themselves from volatility. Can the strength of these three stocks spill into 2023?

Amgen (AMGN) Stock Moves -0.2%: What You Should Know

Amgen (AMGN) closed the most recent trading day at $263.39, moving -0.2% from the previous trading session.

Mirati's (MRTX) Krazati Gets Breakthrough Therapy Tag for CRC

The FDA bestows a Breakthrough Therapy designation to Mirati's (MRTX) Krazati (adagrasib) for treating patients with advanced, KRAS-mutated colorectal cancer.

The Zacks Analyst Blog Highlights Broadcom, United Parcel Service, Amgen, America Movil and Manulife Financial

Broadcom, United Parcel Service, Amgen, America Movil and Manulife Financial are part of the Zacks top Analyst Blog.

Sheraz Mian headshot

Q4 Earnings Season Update and Analyst Reports for Broadcom, UPS & Amgen

Today's Research Daily features update on the Q4 earnings season and new research reports on Broadcom (AVGO), UPS (UPS), Amgen (AMGN) and 16 other stocks.

Amgen (AMGN) Stock Moves -0.64%: What You Should Know

In the latest trading session, Amgen (AMGN) closed at $265.70, marking a -0.64% move from the previous day.

Cytokinetics (CYTK) Up Despite Unfavorable FDA Committee Voting

Cytokinetics (CYTK) gets an unfavorable recommendation from CRDAC on omecamtiv mecarbil for the treatment of heart failure with reduced ejection fraction.

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

5 Stocks to Watch on Dividend Hikes Before 2022 Wraps Up

Investors may keep a tab on LW, NUE, PWRr, TTC, and AMGN which have lately hiked their dividend payments to reward investors.

Biotech Stock Roundup: HZNP Surges on AMGN Offer, TRDA Gains on VRTX Deal & More

Acquisitions news from HZNP and AMGN form the key highlights from the biotech sector during the past week.

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Amgen (AMGN) closed at $272.26, marking a -1.63% move from the previous day.

Andrew Rocco headshot

Trending Today: 5 Stocks in the News

So far this week, several stocks have had headline-driven catalysts. We will cover 5 stocks trending in the news.

Sweta Killa headshot

Amgen to Buy Horizon Therapeutics: ETFs to Bet On

Amgen (AMGN) has agreed to buy Horizon Therapeutics PLC (HZNP) for $27.8 billion. This put the spotlight on pharma ETFs, which could be the best way for investors to tap the opportunity arising from the proposed deal.

Vaishali Doshi headshot

5 Dow Stocks That Helped the Index Minimize Loss in 2022

Here we have shortlisted five stocks - CVX, MRK, AMGN, TRV and IBM- that have fared better than the Dow Jones Index this year and have more upside potential for investment consideration.

Company News for Dec 13, 2022

Companies in The News Are: COUP,HZNP,AMGN,RIVN,BA

Mirati (MRTX) Up on FDA Nod to Adagrasib for KRAS Mutated NSCLC

The accelerated approval of Mirati Therapeutics' (MRTX) Krazati is based on ORR and DOR data from the phase II registration-enabling cohort of the KRYSTAL-1 study.

Amgen (AMGN) to Buy Horizon Therapeutics For $27.8 Billion

Amgen (AMGN) wins the race to buy Horizon Therapeutics and makes an acquisition offer of $27.8 billion.

Wall Street Awaits Key Fed FOMC Decision

Wall Street Awaits Key Fed FOMC Decision